Co-Treatment With Resveratrol and FGF1 Protects Against Acute Liver Toxicity After Doxorubicin Treatment via the AMPK/NRF2 Pathway

Doxorubicin (DOX), an anthracycline type of chemotherapy, is an effective therapy for several types of cancer, but serious side effects, such as severe hepatotoxicity, limit its use currently. Accordingly, an effective therapeutic strategy to prevent DOX-related hepatotoxicity is urgently needed. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xianchou, Liu, Qingbo, Li, Jiahao, Xiao, Mengjie, Gao, Ting, Zhang, Xiaohui, Lu, Guangping, Wang, Jie, Guo, Yuanfang, Wen, Peinan, Gu, Junlian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468578/
https://www.ncbi.nlm.nih.gov/pubmed/36110535
http://dx.doi.org/10.3389/fphar.2022.940406

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468578/
https://www.ncbi.nlm.nih.gov/pubmed/36110535
http://dx.doi.org/10.3389/fphar.2022.940406

Ejemplares similares